Trials / Completed
CompletedNCT00946686
To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions
A Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Sandoz · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
To demonstrate the relative bioavailability, parallel study Of Leflunomide 20 mg tablets under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Leflunomide 20 mg Tablets (Geneva Pharmaceutical) | |
| DRUG | Arava 20 mg Tablets (Aventis Pharmaceutical, Inc.) |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2002-09-01
- Completion
- 2002-09-01
- First posted
- 2009-07-27
- Last updated
- 2017-03-28
Source: ClinicalTrials.gov record NCT00946686. Inclusion in this directory is not an endorsement.